| Product NDC: | 13913-001 |
| Proprietary Name: | Proquin |
| Non Proprietary Name: | ciprofloxacin hydrochloride |
| Active Ingredient(s): | 500 mg/1 & nbsp; ciprofloxacin hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 13913-001 |
| Labeler Name: | Depomed, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021744 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20051001 |
| Package NDC: | 13913-001-91 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (13913-001-91) > 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
| NDC Code | 13913-001-91 |
| Proprietary Name | Proquin |
| Package Description | 1 BLISTER PACK in 1 CARTON (13913-001-91) > 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
| Product NDC | 13913-001 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ciprofloxacin hydrochloride |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20051001 |
| Marketing Category Name | NDA |
| Labeler Name | Depomed, Inc. |
| Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |